Inventor · disambiguated record
Yonghan Hu
Also filed as: HU YONGHAN
21 granted patents·17 pending applications·83 citations·filing 1998–2025
92Inventor score
Files withGENENTECH INC10EVOPOINT BIOSCIENCES CO LTD8SUZHOU SINOVENT PHARMACEUTICALS CO LTD5WYETH CORP5XDCEXPLORER SHANGHAI CO LTD4
Top patents by PatentIndex Score
38 records- 0195US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0293US7432279B24,6-diamino-[1,7]naphthyridine-3-carbonitrile inhibitors of Tpl2 kinase and methods of making and using the sameWYETH CORP·Filed 2006·Granted Oct 7, 2008·35 cites·31 claims
- 0390US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0481US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 0575US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 0674US6147159ACompositions for organic synthesis on solid phase and methods of using the sameARGONAUT TECHNOLOGIES·Filed 1998·Granted Nov 14, 2000·34 cites·23 claims
- 0773US11807660B2Peptide compound and application thereof, and composition containing peptide compoundXDCEXPLORER SHANGHAI CO LTD·Filed 2022·Granted Nov 7, 2023·0 cites·8 claims
- 0870US11981753B2Peptide compound and application thereof, and composition containing peptide compoundSHANGPHARMA INNOVATION INC·Filed 2022·Granted May 14, 2024·0 cites·1 claims
- 0968US2024209023A1Peptide compound, application thereof and composition containing sameXDCEXPLORER SHANGHAI CO LTD·Filed 2024·Application pending·0 cites
- 1067US10952995B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Mar 23, 2021·0 cites·32 claims
- 1166US7268135B2Biaryl sulfonamides and methods for using sameWYETH CORP·Filed 2004·Granted Sep 11, 2007·2 cites·11 claims
- 1264US11944606B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2021·Granted Apr 2, 2024·0 cites·20 claims
- 1363US11427615B2Peptide compound and application thereof, and composition containing peptide compoundXDCEXPLORER SHANGHAI CO LTD·Filed 2018·Granted Aug 30, 2022·0 cites·2 claims
- 1463US7420001B2Biaryl sulfonamides and methods for using sameWYETH CORP·Filed 2004·Granted Sep 2, 2008·2 cites·16 claims
- 1563US2025387402A1Polysubstituted benzene compound and preparation method and use thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2025·Application pending·0 cites
- 1662US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1760US12390472B2Polysubstituted benzene compound and preparation method and use thereofSUZHOU SINOVENT PHARMACEUTICALS CO LTD·Filed 2019·Granted Aug 19, 2025·0 cites·8 claims
- 1860US12129312B2Peptide compound, application thereof and composition containing sameXDCEXPLORER SHANGHAI CO LTD·Filed 2018·Granted Oct 29, 2024·0 cites·2 claims
- 1960US7923446B2Biaryl sulfonamides and methods for using sameWYETH LLC·Filed 2007·Granted Apr 12, 2011·0 cites·18 claims
- 2054US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 2154US2010137298A1Biaryl Sulfonamides and Methods for Using SameWYETH CORP·Filed 2008·Application pending·0 cites
- 2253US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 2353US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
- 2451US2024327401A1Fused ring compound, pharmaceutical composition, and application thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2551US2024246978A1Phenyldihydropyrimidine compound and use thereofHEPAGENE THERAPEUTICS HK LTD·Filed 2022·Application pending·0 cites
- 2648US11180475B2Crystal form I of a 5-aminopyrazole carboxamide compound as BTK inhibitorSINOMAB BIOSCIENCE LTD·Filed 2018·Granted Nov 23, 2021·0 cites·7 claims
- 2748US11078202B2β-lactamase inhibitor and use thereofSUZHOU SINOVENT PHARMACEUTICALS CO LTD·Filed 2020·Granted Aug 3, 2021·0 cites·19 claims
- 2848US2025333541A1Antibody, and drug conjugate and use thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 2948US2024294518A1Nitrogen-containing heterocyclic compoundEVOPOINT BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 3047US11591342B2Heterocyclic compound, application thereof and pharmaceutical composition comprising sameSUZHOU SINOVENT PHARMACEUTICALS CO LTD·Filed 2019·Granted Feb 28, 2023·0 cites·14 claims
- 3147US2024409628A1Antibody, antibody-drug conjugate thereof and use thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 3244US2023061083A1Kras g12c inhibitor compound and use thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 3343US2023115907A1Heterocyclic compound and pharmaceutical composition, preparation method, intermediate and use thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 3442US2023110378A1Monobactam compound and use thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 3539US2006264460A13-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the sameWYETH CORP·Filed 2006·Application pending·0 cites
- 3639US2021046057A1Beta-lactamase inhibitor and use thereofSUZHOU SINOVENT PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 3738US11453674B2Heterocyclic compound, preparation method and use thereof in medicineSUZHOU SINOVENT PHARMACEUTICALS CO LTD·Filed 2019·Granted Sep 27, 2022·0 cites·3 claims
- 3837US2019284192A1Nitrogenous macrocyclic compound, preparation method therefor, pharmaceutical composition and application thereofLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yonghan Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →